Delivery Order SPE2DB20D3101-SPE2DB22FH4C8
Award Date
1/5/22
Potential Completion Date
1/6/22
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $1,007.38. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of 4,564,320 units of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $2,389.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $2,321.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,539,267 units of Ramipril 10 mg capsules, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.20 firm fixed-price delivery order covers the supply of RAMIPRIL 10 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver 100-count bottles of Ramipril 10 mg capsules. The $1,248.24 delivery order was awarded by the Defense Logistics Agency (DLA) as part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,693.69 delivery order contract provides Ramipril 10 MG capsules to support military and veteran healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,779.78 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a medication used to treat high blood pressure and heart failure. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This federal contract award, valued at $12,976.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 8, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $2,268.98 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, on January 10, 2022, with a completion date of January 11, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award is for the delivery of Ramipril 10 mg capsules (500 count) to the Defense Logistics Agency (DLA). The $4,779.73 firm fixed-price delivery order was awarded on February 25, 2022 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 28, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...